Form 4: Balchem Executive Sells Shares for Tax Obligations

Frederic Boned, SVP/GM at Balchem Corp, disposed of 1,085 shares of common stock to cover tax withholdings related to restricted stock vesting.

Summary

• Frederic Boned, SVP/GM, Human Nutrition & Health at Balchem Corporation (BCPC), reported a transaction on October 31, 2025.
• The transaction involved the disposition of 1,085 shares of Balchem Common Stock.
• These shares were withheld to cover withholding taxes due upon the vesting of restricted shares.
• The restricted shares were originally granted on October 31, 2022.
• The price per share for the disposed securities was $153.39.
• Following this transaction, Frederic Boned directly beneficially owns 5,645 shares of Common Stock.
• Additionally, 415 shares are indirectly beneficially owned through a 401(k) Plan.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to tax withholding upon restricted stock vesting, which is neutral in terms of company performance or insider sentiment.

Future Outlook

This filing is a report of an insider transaction for tax purposes and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across all publicly traded companies and does not reflect specific industry trends or competitive dynamics.

Comparison to Industry Standards

• The disposition of shares to cover tax obligations upon the vesting of restricted stock is a standard practice for executive compensation plans across various industries, including the human nutrition and health sector where Balchem operates.
• This type of transaction is not indicative of a discretionary sale and is consistent with typical equity compensation structures seen in companies like DSM-Firmenich, Kerry Group, or Ingredion, which also operate in specialized nutrition and ingredient markets.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's view of the company's prospects.

Key Dates

Recommendation

The transaction is a routine disposition of shares to cover tax obligations upon the vesting of restricted stock and does not reflect a discretionary sale or change in the company's fundamental outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Balchem, BCPC, Form 4, Insider Transaction, Stock Sale, Frederic Boned, Restricted Stock, Tax Withholding